Otrivine Sinusitis Relief (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivine Sinusitis Relief, is a decongestant presented as a nasal spray for topical use. It relieves nasal congestion associated with sinusitis, allergic rhinitis and the common cold in adults and children. GNH USA supplies Otrivine Sinusitis Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline hydrochloride is a topical decongestant that acts on the nasal mucosa to reduce swelling. - Acute sinusitis: reduces nasal congestion and improves airflow. - Allergic rhinitis: alleviates nasal blockage caused by allergic inflammation. - Common cold: provides temporary relief of nasal congestion.

Nasal decongestant sprays may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Dryness: dryness of the nasal mucosa. - Sneezing: transient increase in sneezing. - Headache: mild headache.

Serious or Rare Side Effects: - Nasal septum perforation: rare tissue damage requiring medical attention. - Rebound congestion: worsening nasal blockage after prolonged use. - Hypertension: systemic absorption may raise blood pressure in susceptible individuals.

Before using Otrivine Sinusitis Relief, consider the following safety measures. - Pregnancy: consult a healthcare provider before use. - Breastfeeding: use only if benefits outweigh potential risks. - Age restrictions: not recommended for children under 6 years without medical advice. - Duration of use: limit to 3‑5 days to avoid rebound congestion. - Concurrent nasal surgery: avoid use immediately before or after procedures. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline hydrochloride may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive events. - Systemic decongestants (e.g., pseudoephedrine): additive vasoconstrictive effect.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: monitor blood pressure. - Beta‑blockers: may blunt systemic effects. - Other nasal sprays (e.g., steroids): assess for irritation.